AR047568A1 - Endoprotesis recubierta con farmaco terapeuticamente activo. - Google Patents
Endoprotesis recubierta con farmaco terapeuticamente activo.Info
- Publication number
- AR047568A1 AR047568A1 ARP040104666A ARP040104666A AR047568A1 AR 047568 A1 AR047568 A1 AR 047568A1 AR P040104666 A ARP040104666 A AR P040104666A AR P040104666 A ARP040104666 A AR P040104666A AR 047568 A1 AR047568 A1 AR 047568A1
- Authority
- AR
- Argentina
- Prior art keywords
- endoprotesis
- pharmaco
- covered
- therapeutically active
- restenosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Liberacion local de un inhibidor de la Janus quinasa 3 (JAK3), en particular desde una endoprotesis intravascular, directamente desde los microporos de la endoprotesis o mezclado o unido a un recubrimiento polimérico aplicado sobre la endoprotesis, para inhibir la proliferacion tisular neoíntima y, por lo tanto, prevenir la reestenosis. También facilita el rendimiento de la endoprotesis en la inhibicion de la reestenosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53083803P | 2003-12-17 | 2003-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR047568A1 true AR047568A1 (es) | 2006-01-25 |
Family
ID=34738607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040104666A AR047568A1 (es) | 2003-12-17 | 2004-12-15 | Endoprotesis recubierta con farmaco terapeuticamente activo. |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR047568A1 (es) |
TW (1) | TW200522948A (es) |
WO (1) | WO2005063318A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7713297B2 (en) | 1998-04-11 | 2010-05-11 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
JP2009542359A (ja) | 2006-06-29 | 2009-12-03 | ボストン サイエンティフィック リミテッド | 選択的被覆部を備えた医療装置 |
EP2068757B1 (en) | 2006-09-14 | 2011-05-11 | Boston Scientific Limited | Medical devices with drug-eluting coating |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
EP2187988B1 (en) | 2007-07-19 | 2013-08-21 | Boston Scientific Limited | Endoprosthesis having a non-fouling surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
WO2009018340A2 (en) | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
WO2009020520A1 (en) | 2007-08-03 | 2009-02-12 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
BRPI1007737A2 (pt) | 2009-04-20 | 2015-09-01 | Auspex Pharmaceuticals Llc | "composto da fórmula estrutural i, composição farmacêutica, método de tratamento de um distúbio mediano por janus quinase 3, método de preparação de um composto da fórmula estrutural ii, e método de preparação de um composto da fórmula estrutural xii" |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9604361D0 (en) * | 1996-02-29 | 1996-05-01 | Pharmacia Spa | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors |
-
2004
- 2004-12-06 WO PCT/IB2004/004024 patent/WO2005063318A1/en active Application Filing
- 2004-12-13 TW TW093138597A patent/TW200522948A/zh unknown
- 2004-12-15 AR ARP040104666A patent/AR047568A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW200522948A (en) | 2005-07-16 |
WO2005063318A1 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR047568A1 (es) | Endoprotesis recubierta con farmaco terapeuticamente activo. | |
SV2008002477A (es) | Combinacion para terapia de hiperplasia benigna de prostata ref. bhc051038-sv | |
WO2007044032A3 (en) | Compositions having a high antiviral and antibacterial efficacy | |
MXPA04011392A (es) | Pirimidina o triazina microbicida para prevenir la tranmision sexual de vih. | |
ES2571779T3 (es) | Inhibidores de cinasa a base de nicotinamida | |
DK1435877T3 (da) | Overtrækning af stents for at forhindre restenose | |
CR6682A (es) | Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias | |
CL2007003594A1 (es) | Compuestos derivados de heterociclos condensados de nitrogeno, inhibidores de transcriptasa inversa no nucleosidicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sida. | |
WO2007103694A3 (en) | Triazine 11-beta hydroxysteroid dehydrogenase type i inhibitors | |
UY28258A1 (es) | Tratamiento terapeutico | |
TW200716183A (en) | Parakeratosis inhibitor, pore-contracting agent and external composition for skin | |
MY142948A (en) | Benzophenones as inhibitors of reverse transcriptase | |
WO2004014893A3 (en) | Antimicrobial aza-bicyclic derivates, their compositions and uses | |
TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
ECSP105178A (es) | Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos | |
TR200401663T1 (tr) | 4-oksokuinolin bileşiği ve bunun HIV integraz inhibitörü olarak kullanımı. | |
MX2007002236A (es) | S-triazolil-alfa-mercaptoacetanilidas como inhibidores de transcriptasa inversa de virus de inmunodeficiencia humana. | |
EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
BRPI0400721A (pt) | Composições que contêm sucralose | |
WO2006024492A3 (en) | Medical implant provided with inhibitors of atp synthesis | |
WO2006113498A3 (en) | 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases | |
CR9068A (es) | Uso de un inhibidor del mtor en el tratamiento de leiomioma del utero | |
WO2003076398A3 (en) | Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors | |
HUP0400648A2 (hu) | Ecteinascidin-743-t tartalmazó tumorellenes kezeléseknél alkalmazható készítmények | |
SE0101932D0 (sv) | Pharmaceutical combinations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |